【疼痛医学 pain medicine】

本帖于 2017-04-06 21:07:51 时间, 由普通用户 弓尒 编辑
回答: 【医学 side effects or Viread & Epivir 】弓尒2017-04-04 10:49:48

https://clinicaltrials.gov/ct2/show/NCT00028249

ClinicalTrials.gov Identifier:
NCT00028249
First received: December 17, 2001
Last updated: March 3, 2008
Last verified: December 2005

Multimodal Pain Management for Cesarean Delivery - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02922985
Sep 29, 2016 - The investigators believe that a multimodal pain management strategy is ... This is a randomized double-blinded, placebo controlled trial.

Improving Cancer Pain Management Using ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT00012896
Cancer pain is a pervasive problem for the person with cancer. Despite advances in knowledge, effective cancer management is infrequently achieved.

The cryoICE™ CryoAnalgesia Study For Pain ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02922153
Sep 26, 2016 - The cryoICE™ CryoAnalgesia Study For Pain Management in Post thoRacic Procedures Via intercOSTal Cryoanalgesia (FROST) (FROST).

Intravenous Lidocaine and Postoperative Pain ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02997215
Dec 6, 2016 - This study was to evaluate the effect of intraoperative intravenous lidocaine on postoperative pain management after laparoscopic ...

IBUPAP Study for Pain Management in Children - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT03088800

Mar 18, 2017 - IBUPAP Study for Pain Management in Children. This study is not yet open for participant recruitment. (see Contacts and Locations). Verified ...

------------

Chronic Pain and Assessment of Sleep - Full Text ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02969434
Nov 17, 2016 - Therapies targeted at improving sleep, including cognitive behavioral therapy, improve both sleep quality and also pain management, and ...

Pain Management in Cancer Patients Using a ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02069743
Feb 18, 2014 - The investigators have developed a mobile application (for use on smart phones) to help cancer patients better manage cancer pain. This study ...

Development and Evaluation of a Methadone ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02335398
Jan 7, 2015 - Methadone is a synthetic mu opioid agonist that has been proved as clinically effective inpain management. However, methadone usage for ...

OPEN Study: Pain Management Treatment Needs ... - ClinicalTrials.gov

https://clinicaltrials.gov/ct2/show/NCT02972606
Nov 18, 2016 - OPEN StudyPain Management Treatment Needs Interviews. This study is currently recruiting participants. (see Contacts and Locations).
 
----------
 
Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Process and Outcomes of Pain Management

This study has been completed.
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00028249
First received: December 17, 2001
Last updated: March 3, 2008
Last verified: December 2005
  Purpose

This study will investigate the most effective approach for managing pain and providing palliative care (lessening of pain or symptoms).

Patients with advanced cancer who are enrolled in a National Cancer Institute (NCI) protocol and will undergo major surgery as part of their treatment may be eligible for this study.

Participants will be randomly assigned to pain management provided by either 1) their attending physician or 2) the Clinical Center's Pain and Palliative Care Service. Patients in the first group may be reassigned to the Pain and Palliative Care Service at any time during the study.

Participants will be interviewed every 3 months for as long as 1 year about their pain, its effect on several areas of their lives, changes in their needs, and how well they think their pain is being managed.. As the patients progress through the NCI study, they will meet regularly and as often as needed with either their attending physician or the Pain and Palliative Care team. Each interview will last about 20 to 30 minutes. With the patient's permission, the interviews will be tape recorded.

 
Condition
Pain
Neoplasm
 
Study Type: Observational
Official Title: A Randomized Study Evaluating the Process and Outcomes of the Pain and Palliative Care Team Intervention
 
Resource links provided by NLM:
   
Further study details as provided by National Institutes of Health Clinical Center (CC):
 
Estimated Enrollment: 298
Study Start Date: December 2001
Estimated Study Completion Date: December 2005
Detailed Description:

Pain is multidimensional. It is more than simply a physiologic or sensory response. Pain management programs are best developed by selecting interventions based on the individual's pain experience. Strategies with several mechanisms of action that complement each other might be selected to work together, thereby maximizing pain relief. The goal of palliative care is to achieve the highest possible quality of life for patients and their families through symptom control and attention to the whole patient, where physical, psychosocial, emotional, and spiritual dimensions are addressed. Provision of relief from pain and distressing symptoms is best served by a specialized interdisciplinary team with a comprehensive approach. The continuity of care for the patient and family is supported by communication and a strong partnership with the primary biomedical research team and the palliative care team.

Despite a number of descriptive studies exploring the effectiveness of specialized pain and palliative care teams, the paucity of good evaluations, with any comparative design, urgently needs to be addressed. This is a randomized, repeated measures, evaluation study to explore the effectiveness of the inpatient Pain and Palliative Care Service intervention. The data collected during this study will not only include outcomes of the intervention, but also patient and family perceptions of the care delivery process including issues surrounding communication with health care providers. Patients with advanced malignancies who are currently participating in NCI Surgery Branch protocols will be asked to participate in a pain and symptoms management evaluation study. Each patient and a designated family member will be asked to complete a series of questionnaires over time exploring physical, psychosocial and emotional correlates of pain and symptom management. Data will be analyzed using multivariate statistics.

  Eligibility
 
Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

INCLUSION CRITERIA:

Patients with advanced malignancies who are currently undergoing major surgical procedures in NCI Surgery Branch will be recruited to participate in a pain and symptoms management evaluation study.

Inclusion criteria are stated in the parent protocols.

Although each patient will be asked to identify a family member/significant other to participate in the study, patients will be eligible for inclusion regardless of whether they identify a family member for participation in the family questionnaires.

EXCLUSION CRITERIA:

All exclusions are stated in the NCI Surgery Branch parent protocols.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies. 

Please refer to this study by its ClinicalTrials.gov identifier: NCT00028249

Locations
United States, Maryland
National Institutes of Health Clinical Center (CC)  
Bethesda, Maryland, United States, 20892
Sponsors and Collaborators
National Institutes of Health Clinical Center (CC)
  More Information

Publications:  
ClinicalTrials.gov Identifier: NCT00028249     History of Changes
Other Study ID Numbers: 020053 
02-CC-0053 
Study First Received: December 17, 2001
Last Updated: March 3, 2008

Keywords provided by National Institutes of Health Clinical Center (CC):
Patient Satisfaction
Self Efficacy
Social Support
Symptom Management
Advanced Malignancies
Pain Intervention


ClinicalTrials.gov processed this record on April 06, 2017

 

 

---------------

In addition to many well-known, established treatments, such as non-narcotic drugs (acetaminophenaspirin and ibuprofen, for example) and narcotic medications (such as morphine and methadone), several newer methods are being used to treat chronic pain, with varying degrees of success.

 

transcutaneous electrical nerve stimulation(TENS) device, which delivers a small electrical current to the skin surrounding the painful area(s)

 marijuana for medical purposes 

Spinal cord stimulation (SCS) involves implanting a small device beneath the skin that creates small electrical impulses near the base of the spine. Sometimes called a "pain pacemaker," SCS devices can now work via remote control, which allows the patient to adjust the level of the electrical signals in response to increasing or decreasing pain.

 

 a "pain pump" or "drug pump" is a device implanted beneath the skin but this unit actually delivers medication directly to the fluid surrounding the spinal cord.

 

Use of a pain pump is not widespread because of the expense involved, but for certain patients, these devices have proven effective because the amount of medication needed is lower, which can reduce the negative side effects experienced with other drug-delivery techniques.

Unconventional treatments for chronic pain have grown significantly in the past two decades due to the growing acceptance of non-conventional medical methods, such as herbal supplements, yoga, meditation, etc. These various processes are collectively referred to as CAM, or complementary and alternative medicine. Briefly, a complementary technique will be used along with other pain-control treatments, while an alternative method is used in lieu of another type of treatment.

The list of CAM treatment types is long, but includes massage therapy, acupuncture, hypnosis, magnetic therapy, tai chi, and herbal or dietary supplements, to name a few.

 

http://www.academia.edu/6166869/SYMPOSIUM_PAIN_MANAGEMENT_CURRENT_TRENDS_Pain_Management_A_New_Super-Speciality

 

-----------

 

1. Growth in alternative therapies: While alternative therapies are certainly not new, they are an emerging trend in the U.S. as consumers embrace a natural lifestyle approach to health and wellness. The strong relief ratio achieved by these providers provides fuel to this trend and the popularity of these healthcare specialists will likely continue to grow. As of 2016, roughly 23% of adults trust homeopathic medicine, and 22% prefer alternative medicine to standard medical practices.

Further, Packaged Facts' survey found that among adults who suffered from debilitating pain within the past year, 68% visited a traditional healthcare professional, such as a family/general practice doctor or specialized doctor. However, nearly four out of 10 sufferers visited an alternative healthcare provider, such as an acupuncturist, chiropractor, massage therapist, etc.—a point that shows strong acceptance of alternative methods, whether used in place of traditional healthcare or in tandem.

2. Heavier focus on health and diet: Health and diet considerations play a key role in helping consumers manage their pain. Indeed, food and diet are considered part of 45% of pain sufferers' preferred approach to managing minor everyday pain, and 23% of their preferred approach to managing the "worst pain imaginable." 

Further, consumers are hungry for information and tools that can help them lead healthier, more productive, more fulfilled lives—a hunger that only increases among those challenged by illness and pain because they are that much further removed from those intuitively human goals. Health and diet tools—ranging from vitamins and supplements to functional foods and beverages to organic and natural and beyond—have a significant role to play in satiating that hunger and achieving the universal goal of a more fulfilled life.

3. Exercise and weight management part of broader treatment: While weight management is a challenge for many, it is more prevalently so among those challenged by pain-centric illnesses and conditions. Illness and the pain associated with it can curtail activity, from everyday functions to specific behaviors closely associated with health and wellness. Exercising regularly takes a hit, as does the ability to control weight, and the likelihood of being overweight skyrockets.

Nevertheless, when paired with diet and healthy lifestyle efforts, incorporating moderate bouts of exercise to manage weight can be part of a broader pain management treatment strategy as excess weight can compound or exacerbate already existing pain.

4. Rising interest in homeopathic and functional pain medication: Consumers want products to be multi-functional, and pain relievers are no different. Pain sufferers exhibit significant interest in retail products that can help treat their pain while featuring value-added functional claims. 

Makers and marketers should consider adding homeopathic or herbal qualities that can help users feel like they are doing something healthy for their entire body and not just eradicating their pain. The aromatherapy and essential oils market has gathered steam from the natural health and wellness megatrend.

5. Caffeine for more than just coffee: While the power of caffeine continues to drive sales of coffee and energy drinks, sating the appetites of consumers seeking an energy boost, it is also recognized as a pain remedy, particularly for migraines. For example, consider Excedrin Extra Strength, which promises that its "combination of active ingredients –  Acetaminophen, Aspirin and Caffeine – offer a fast-acting, non-prescription headache pain reliever alternative."

Studies also suggest that caffeine has a broader scope of pain reduction potential, ranging from serving as a useful complement to opioid analgesic use among patients with advanced cancer to complementing acetaminophen in addressing acute back pain.

About the Report

Pain Management in the U.S.: Consumer Strategies, the first in a new segment for Packaged Facts, provides industry participants with an organized, insight-driven roadmap to navigating consumers' pain treatment and management strategies, helping to leverage market opportunity. The report focuses on how adults approach and treat their physical pain, emphasizing consumer survey analysis, including trends over time. The report studies two distinct groups: pain sufferers and adults who have selected illnesses/conditions strongly associated with physical pain and pain management. Demographic analysis of these groups is woven into report analysis. Content is further segmented by the nature of consumers' physical pain and chosen pain treatment methods and outcomes.

For additional information about Pain Management in the U.S.: Consumer Strategies, including purchase options, the abstract, table of contents, and related reports click:  http://www.packagedfacts.com/Pain-Management-Consumer-10595686/.   

About Packaged Facts 

Packaged Facts, a division of MarketResearch.com, publishes market intelligence on a wide range of consumer market topics, including consumer demographics and shopper insights, consumer financial products and services, consumer goods and retailing, consumer packaged goods, and pet products and services.  Packaged Facts also offers a full range of custom research services. Reports can be purchased at our company website and are also available through MarketResearch.com.

For more essential insights from Packaged Facts be sure to follow us on Twitter and Google+. For infographics, tables, charts and other visuals, follow Packaged Facts on Pinterest.

Please link any media references to our reports or data to www.packagedfacts.com.

Press Contact:
Daniel Granderson
240.747.3000
dgranderson@marketresearch.com

 

 

所有跟帖: 

【吗啡 opioid receptors 受体】-- wiki -弓尒- 给 弓尒 发送悄悄话 弓尒 的博客首页 (296995 bytes) () 04/06/2017 postreply 22:25:00

【on opioids receptors 】 -弓尒- 给 弓尒 发送悄悄话 弓尒 的博客首页 (29451 bytes) () 04/06/2017 postreply 22:41:18

【Somatostatin, also known as growth hormone–inhibiting hormone ( -弓尒- 给 弓尒 发送悄悄话 弓尒 的博客首页 (6063 bytes) () 04/06/2017 postreply 22:29:22

请您先登陆,再发跟帖!